Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.7%

2 terminated out of 43 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

30%

13 trials in Phase 3/4

Results Transparency

19%

5 of 26 completed with results

Key Signals

5 with results93% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (16)
Early P 1 (1)
P 1 (2)
P 2 (4)
P 3 (8)
P 4 (5)

Trial Status

Completed26
Unknown12
Terminated2
Recruiting1
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT06816875Not ApplicableCompletedPrimary

Comparison of the User Experience of Four Nasal Aspirators in Infants

NCT02484417Phase 1CompletedPrimary

Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers

NCT06065176Phase 4Completed

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

NCT07346963Not Yet Recruiting

RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV

NCT07154992Not ApplicableRecruitingPrimary

Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children

NCT06573814Phase 2CompletedPrimary

The Effects of Bio Gelee Royale Forte on Immune Health in Healthy Adults

NCT06689995Not ApplicableCompletedPrimary

A Clinical Study to Determine the Safety and Efficacy of an Oral Supplementation of Bio-Immune®for Managing Upper Respiratory Tract Infection and Its Symptoms.

NCT05915390Not ApplicableCompleted

Walnut and Immunity Study

NCT05835375Not ApplicableUnknownPrimary

A Study to Evaluate the Efficacy of EQ-778 on Upper Respiratory Tract Health Status in Healthy Adults

NCT06149117Phase 4CompletedPrimary

Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China

NCT06140446Not ApplicableUnknownPrimary

Effect of eHealth on AB Use of Children With Acute, Uncomplicated URTIs

NCT06052540Not ApplicableUnknownPrimary

Probiotic Supplementation in Children Affected by Upper Respiratory Infections

NCT06002594Not ApplicableCompletedPrimary

Examination of the Effectiveness of Nasal Irrigation Techniques in Infants With Nasal Congestion

NCT05569330Not ApplicableUnknownPrimary

Effect of Aerosol Filtering on Infectious Diseases in Day Care

NCT05840926Not ApplicableCompletedPrimary

Probiotic S. Salivarius K12 for the Prevention of Upper Respiratory Tract Infection in Nursery-age Children

NCT04239521Completed

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

NCT04479657Early Phase 1UnknownPrimary

Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection

NCT05612893Unknown

Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study

NCT05435144Not ApplicableUnknownPrimary

Elderberry for Immune Support

NCT04930900Phase 1CompletedPrimary

Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection

Scroll to load more

Research Network

Activity Timeline